Related Experiment Video
Updated: Jan 17, 2026

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
Left Ventricular Mass-to-Strain Ratio to Predict Change in Left Ventricular Hypertrophy and Prognosis in Hypertensive
In-Chang Hwang1,2, Hyue Mee Kim3, Jiesuck Park1
1Department of Cardiology, Cardiovascular Center Seoul National University Bundang Hospital Seongnam Gyeonggi South Korea.
Background:
A typical hypertensive heart disease phenotype is the left ventricular hypertrophy (LVH) and dysfunction, measurable via LV mass and global longitudinal strain. We aimed to evaluate the LV mass-to-strain ratio (LV-MSR) as a marker of the clinical course in patients with hypertensive heart disease.
Methods:
We retrospectively analyzed consecutive patients who underwent echocardiography at the time of hypertension diagnosis and at 6- to 18-month intervals in tertiary centers from 2006 to 2021. Associations of LV-MSR with LVH changes and clinical outcomes (cardiovascular death and heart failure hospitalization occurring after the second echocardiogram) were assessed using time-dependent receiver-operating characteristic analysis and multivariable Cox regression.
Results:
Among 1600 patients (mean age 65.1 years; 61.1% male), 23.4% had concentric LVH, and 21.5% had eccentric LVH at baseline. The median interval between echocardiograms was 10.2 months (interquartile range, 6.8-13.4). LV-MSR showed the highest discriminatory value for LVH changes (area under the curve, 0.726 [95% CI, 0.685-0.760]), outperforming LV mass index (area under the curve, 0.690 [95% CI 0.648-0.728]; P<0.001) and LV-global longitudinal strain (area under the curve, 0.600 [95% CI 0.558-0.647]; P<0.001). Higher LV-MSR was significantly associated with new-onset LVH (global test P<0.001) and persistent LVH (global test P<0.001). LV-MSR was an independent prognosticator, both as a continuous (adjusted hazard ratio [HR], 1.044 per +1 g/m2 per % [95% CI 1.020-1.069]) or categorical variable (adjusted HR 2.267 for LV-MSR, ≥6.52 g/m2 per % [95% CI 1.520-3.381]). These associations remained consistent across subgroups by sex and baseline LVH status.
Conclusions:
LV-MSR independently predicts LVH changes and clinical outcomes in hypertensive heart disease, serving as a superior prognostic marker compared with LV mass index or LV-global longitudinal strain alone.
More Related Videos
09:05Transthoracic Speckle Tracking Echocardiography for the Quantitative Assessment of Left Ventricular Myocardial Deformation
Published on: October 20, 2016
07:24Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction